AI assistant
Sending…
Inogen Inc — Director's Dealing 2017
Apr 26, 2017
33625_dirs_2017-04-25_d3cbe07e-c0c5-475d-a1fb-ef1d69fca0d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2017-04-24
Reporting Person: Myers Byron (EVP, Sales and Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-24 | Common Stock | M | 10000 | $16.62 | Acquired | 45185 | Direct |
| 2017-04-24 | Common Stock | S | 10000 | $80.00 | Disposed | 35185 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-24 | Stock Option (right to buy) | $16.62 | M | 10000 | Disposed | 2021-03-31 | Common Stock (10000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2016.
F2: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.
More from Inogen Inc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3